Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


Oliena Studio

Stroke and language recovery: 9000+ videos

EspañolItalianoSarduEnglish | PDF+


  Gynecology

  Free Subscription


09.09.2019

4 Am J Obstet Gynecol
1 Am J Surg Pathol
2 BMC Cancer
1 BMJ
1 Cancer Res
1 Clin Cancer Res
6 Eur J Obstet Gynecol Reprod Biol
2 Gynecol Endocrinol
10 Gynecol Oncol
1 Int J Cancer
10 Int J Gynaecol Obstet
1 J Clin Pathol
5 JAMA
5 Lancet
1 Lancet Oncol
2 Oncogene


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Am J Obstet Gynecol

  1. MORSE AN
    Hysterectomy and the risk of osteoporosis.
    Am J Obstet Gynecol. 2019 Aug 29. pii: S0002-9378(19)31053.
    PubMed     Text format    

  2. CHRISTIANSON MS, Wodi P, Talaat K, Halsey N, et al
    Primary Ovarian Insufficiency and Human Papilloma Virus Vaccines: A Review of the Current Evidence.
    Am J Obstet Gynecol. 2019 Aug 31. pii: S0002-9378(19)31060.
    PubMed     Text format     Abstract available

  3. CHOI HG, Lee SW
    Reply: Letter to the Editors Hysterectomy and the Risk of Osteoporosis.
    Am J Obstet Gynecol. 2019 Aug 29. pii: S0002-9378(19)31054.
    PubMed     Text format    

  4. CREAN-TATE KK, Faubion SS, Pederson HJ, Vencill JA, et al
    Management of Genitourinary Syndrome of Menopause in Female Cancer Patients: A Focus on Vaginal Hormonal Therapy.
    Am J Obstet Gynecol. 2019 Aug 29. pii: S0002-9378(19)31057.
    PubMed     Text format     Abstract available


    Am J Surg Pathol

  5. SAIJO M, Nakamura K, Ida N, Nasu A, et al
    Histologic Appearance and Immunohistochemistry of DNA Mismatch Repair Protein and p53 in Endometrial Carcinosarcoma: Impact on Prognosis and Insights Into Tumorigenesis.
    Am J Surg Pathol. 2019 Aug 30. doi: 10.1097/PAS.0000000000001353.
    PubMed     Text format     Abstract available


    BMC Cancer

  6. YU X, Liang C, Zhang Y, Zhang W, et al
    Inhibitory short peptides targeting EPS8/ABI1/SOS1 tri-complex suppress invasion and metastasis of ovarian cancer cells.
    BMC Cancer. 2019;19:878.
    PubMed     Text format     Abstract available

  7. ZHU H, Tao X, Zhou L, Sheng B, et al
    Expression of thioredoxin 1 and peroxiredoxins in squamous cervical carcinoma and its predictive role in NACT.
    BMC Cancer. 2019;19:865.
    PubMed     Text format     Abstract available


    BMJ

  8. IACOBUCCI G
    WHO updates guidance on hormonal contraceptive use for women at high HIV risk.
    BMJ. 2019;366:l5335.
    PubMed     Text format    


    Cancer Res

  9. ROBERTS AL, Huang T, Koenen KC, Kim Y, et al
    Posttraumatic stress disorder (PTSD) is associated with increased risk of ovarian cancer: a prospective and retrospective longitudinal cohort study.
    Cancer Res. 2019 Sep 5. pii: 0008-5472.CAN-19-1222.
    PubMed     Text format     Abstract available


    Clin Cancer Res

  10. DE JONGE MM, Ritterhouse LL, de Kroon CD, Vreeswijk MPG, et al
    Germline BRCA-associated Endometrial Carcinoma is a Distinct Clinicopathologic Entity.
    Clin Cancer Res. 2019 Sep 6. pii: 1078-0432.CCR-19-0848.
    PubMed     Text format     Abstract available


    Eur J Obstet Gynecol Reprod Biol

  11. IWAGAKI S, Takahashi Y, Chiaki R, Asai K, et al
    Cardiomegaly of the larger twin in monochorionic twin pregnancies warrants neonatal intensive care even without twin-to-twin transfusion syndrome.
    Eur J Obstet Gynecol Reprod Biol. 2019;241:82-87.
    PubMed     Text format     Abstract available

  12. WHITAKER LHR, Byrne D, Hummelshoj L, Missmer SA, et al
    Proposal for a new ICD-11 coding classification system for endometriosis.
    Eur J Obstet Gynecol Reprod Biol. 2019 Aug 26. pii: S0301-2115(19)30394.
    PubMed     Text format    

  13. NAVARRO A, Sison JM, Puno R, Quizon T, et al
    Reducing the incidence of pregnancy-related urinary tract infection by improving the knowledge and preventive practices of pregnant women.
    Eur J Obstet Gynecol Reprod Biol. 2019;241:88-93.
    PubMed     Text format     Abstract available

  14. AYUK P, Farnworth A, Rees J, Khunda A, et al
    Obstetric anal sphincter injuries before and after the introduction of the Episcissors-60: A multi-centre time series analysis.
    Eur J Obstet Gynecol Reprod Biol. 2019;241:94-98.
    PubMed     Text format     Abstract available

  15. VYAWAHARE B, Hart F, De Mello WF
    Response to Editor: European Journal of Obsterics and Gynecology and Reproductive Biology 2019 Mar; 234:49-52. Review Article: Managing pain after synthetic Mesh implants in pelvic surgery, Philip Tooz-Hobson, Linda Cardozo, Timothy Hillard.
    Eur J Obstet Gynecol Reprod Biol. 2019 Aug 14. pii: S0301-2115(19)30331.
    PubMed     Text format    

  16. TAN S, Tao Z, Bian X, Zhao Y, et al
    Ureteral stent placement and percutaneous nephrostomy in the management of hydronephrosis secondary to cervical cancer.
    Eur J Obstet Gynecol Reprod Biol. 2019;241:99-103.
    PubMed     Text format     Abstract available


    Gynecol Endocrinol

  17. PORPORA MG, Scaramuzzino S, Sangiuliano C, Piacenti I, et al
    High prevalence of autoimmune diseases in women with endometriosis: a case-control study.
    Gynecol Endocrinol. 2019 Sep 3:1-4. doi: 10.1080/09513590.2019.1655727.
    PubMed     Text format     Abstract available

  18. BORBA CM, Ferreira CF, Ferreira FV, Perez-Lopez FR, et al
    Effect of sulpiride on menopausal hot flashes: a randomized, double-blind, placebo-controlled clinical trial.
    Gynecol Endocrinol. 2019 Sep 3:1-5. doi: 10.1080/09513590.2019.1658189.
    PubMed     Text format     Abstract available


    Gynecol Oncol

  19. HIRAO N, Iwata T, Tanaka K, Nishio H, et al
    Transcription factor homeobox D9 is involved in the malignant phenotype of cervical cancer through direct binding to the human papillomavirus oncogene promoter.
    Gynecol Oncol. 2019 Aug 30. pii: S0090-8258(19)31478.
    PubMed     Text format     Abstract available

  20. RAFFONE A, Travaglino A, Mascolo M, Carbone L, et al
    TCGA molecular groups of endometrial cancer: Pooled data about prognosis.
    Gynecol Oncol. 2019 Aug 29. pii: S0090-8258(19)31471.
    PubMed     Text format     Abstract available

  21. LONG ROCHE K, Gardner GJ
    State of the science: Evolving role of surgery for the treatment of ovarian cancer.
    Gynecol Oncol. 2019 Aug 28. pii: S0090-8258(19)31468.
    PubMed     Text format    

  22. MCALPINE JN, Gilks CB
    Precision medicine in endometrial cancer.
    Gynecol Oncol. 2019;154:451-453.
    PubMed     Text format    

  23. RADER JS, Pan A, Corbin B, Iden M, et al
    Identification and validation of a prognostic proteomic signature for cervical cancer.
    Gynecol Oncol. 2019 Aug 30. pii: S0090-8258(19)31473.
    PubMed     Text format     Abstract available

  24. ELZAKKERS JCJ, van der Aa MA, van Altena AM, de Hullu JA, et al
    Further insights into the role of tumour characteristics in survival of young women with epithelial ovarian cancer.
    Gynecol Oncol. 2019 Aug 30. pii: S0090-8258(19)31470.
    PubMed     Text format     Abstract available

  25. BJURBERG M, Holmberg E, Borgfeldt C, Floter-Radestad A, et al
    Primary treatment patterns and survival of cervical cancer in Sweden: A population-based Swedish Gynecologic Cancer Group Study.
    Gynecol Oncol. 2019 Aug 30. pii: S0090-8258(19)31474.
    PubMed     Text format     Abstract available

  26. TOZZI R, Traill Z, Campanile RG, Kilic Y, et al
    Diagnostic flow-chart to identify bowel involvement in patients with stage IIIC-IV ovarian cancer: Can laparoscopy improve the accuracy of CT scan?
    Gynecol Oncol. 2019 Aug 31. pii: S0090-8258(19)31477.
    PubMed     Text format     Abstract available

  27. KAY AH, Urban RR, Gray HJ
    Intraperitoneal ports placed at the time of bowel resection for treatment of ovarian cancer: Complications and surgical outcomes.
    Gynecol Oncol. 2019 Sep 3. pii: S0090-8258(19)31472.
    PubMed     Text format     Abstract available

  28. AHMAD TR, Chen LM, Chapman JS, Chen LL, et al
    Medicaid and Medicare payer status are associated with worse surgical outcomes in gynecologic oncology.
    Gynecol Oncol. 2019 Sep 3. pii: S0090-8258(19)31465.
    PubMed     Text format     Abstract available


    Int J Cancer

  29. WOESTENBERG PJ, Bogaards JA, King AJ, Leussink S, et al
    Assessment of herd effects among women and heterosexual men after girls-only HPV16/18 vaccination in the Netherlands: A repeated cross-sectional study.
    Int J Cancer. 2019;144:2718-2727.
    PubMed     Text format     Abstract available


    Int J Gynaecol Obstet

  30. ZENG G, Guo F, Gao Q, Liu C, et al
    Acute gravid uterus torsion: a rare and dangerous obstetric emergency.
    Int J Gynaecol Obstet. 2019 Aug 31. doi: 10.1002/ijgo.12954.
    PubMed     Text format     Abstract available

  31. SOEPNEL LM, Nicolaou V, Huddle KRL, Klipstein-Grobusch K, et al
    Maternal and neonatal outcomes following a diabetic pregnancy within the context of HIV.
    Int J Gynaecol Obstet. 2019 Sep 3. doi: 10.1002/ijgo.12956.
    PubMed     Text format     Abstract available

  32. SHAW R, Baker E, Jie C, Adamian S, et al
    Zika virus knowledge, contraception use, and lessons learned from a Dominican Republic pilot study.
    Int J Gynaecol Obstet. 2019 Sep 3. doi: 10.1002/ijgo.12957.
    PubMed     Text format     Abstract available

  33. BONI S, Tchounga B, Comoe K, Guie P, et al
    Assessment of the scale-up of cervical cancer screening in Abidjan stratified by HIV status.
    Int J Gynaecol Obstet. 2019 Sep 4. doi: 10.1002/ijgo.12959.
    PubMed     Text format     Abstract available

  34. ALVES RD, Rabelo MM, Andrade VR, Cabral RC, et al
    The influence of the levonorgestrel-releasing intrauterine system position on bleeding patterns in reproductive age women.
    Int J Gynaecol Obstet. 2019 Sep 6. doi: 10.1002/ijgo.12962.
    PubMed     Text format     Abstract available

  35. DIAMOND-SMITH N, Phillips B, Percher J, Saxena M, et al
    An intervention to improve the quality of medication abortion knowledge among pharmacists in India.
    Int J Gynaecol Obstet. 2019 Sep 6. doi: 10.1002/ijgo.12960.
    PubMed     Text format     Abstract available

  36. ZAMANE H, Sanou F, Kiemtore S, Kain DP, et al
    Transfusion practices in the care of pregnant women with sickle cell disease in Ouagadougou.
    Int J Gynaecol Obstet. 2019 Sep 6. doi: 10.1002/ijgo.12961.
    PubMed     Text format     Abstract available

  37. CLEEVE A, Sporstol Fonhus M, Lavelanet A
    A systematic review of the effectiveness, safety, and acceptability of medical management of intrauterine fetal death at 14-28 weeks of gestation.
    Int J Gynaecol Obstet. 2019 Sep 6. doi: 10.1002/ijgo.12964.
    PubMed     Text format     Abstract available

  38. STEENHAUT P, Depoix C, Hubinont C, Debieve F, et al
    Changes in fetal membrane histology with cervical insufficiency and transabdominal cerclage.
    Int J Gynaecol Obstet. 2019;146:223-230.
    PubMed     Text format     Abstract available

  39. BEYUO T, Oppong SA, Samba A, Beyuo VM, et al
    Chlamydia trachomatis infection among Ghanaian women undergoing hysterosalpingography for suspected tubal factor infertility.
    Int J Gynaecol Obstet. 2019 Jun 4. doi: 10.1002/ijgo.12875.
    PubMed     Text format     Abstract available


    J Clin Pathol

  40. THURSTON L, Abbara A, Dhillo WS
    Investigation and management of subfertility.
    J Clin Pathol. 2019;72:579-587.
    PubMed     Text format     Abstract available


    JAMA

  41. OWENS DK, Davidson KW, Krist AH, Barry MJ, et al
    Risk Assessment, Genetic Counseling, and Genetic Testing for BRCA-Related Cancer: US Preventive Services Task Force Recommendation Statement.
    JAMA. 2019;322:652-665.
    PubMed     Text format     Abstract available

  42. HESTER DM, Eisenberg L, Guidry-Grimes L
    Regulating Decisions for Incapacitated Pregnant Women.
    JAMA. 2019;322:894-895.
    PubMed     Text format    

  43. DEMARTINO ES, Doyle CK, Mueller PS
    Regulating Decisions for Incapacitated Pregnant Women-Reply.
    JAMA. 2019;322:895.
    PubMed     Text format    

  44. JIN J
    Should I Be Tested for BRCA Mutations?
    JAMA. 2019;322:702.
    PubMed     Text format    

  45. NELSON HD, Pappas M, Cantor A, Haney E, et al
    Risk Assessment, Genetic Counseling, and Genetic Testing for BRCA-Related Cancer in Women: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force.
    JAMA. 2019;322:666-685.
    PubMed     Text format     Abstract available


    Lancet

  46. STAFF AC
    Long-term cardiovascular health after stopping pre-eclampsia.
    Lancet. 2019 Aug 28. pii: S0140-6736(19)31993.
    PubMed     Text format    

  47. CHAPPELL LC, Brocklehurst P, Green ME, Hunter R, et al
    Planned early delivery or expectant management for late preterm pre-eclampsia (PHOENIX): a randomised controlled trial.
    Lancet. 2019 Aug 28. pii: S0140-6736(19)31963.
    PubMed     Text format     Abstract available

  48. BERAL V, Peto R, Pirie K, Reeves G, et al
    Menopausal hormone therapy and 20-year breast cancer mortality.
    Lancet. 2019 Aug 29. pii: S0140-6736(19)32033.
    PubMed     Text format    

  49. KOTSOPOULOS J
    Menopausal hormones: definitive evidence for breast cancer.
    Lancet. 2019 Aug 29. pii: S0140-6736(19)31901.
    PubMed     Text format    


  50. Type and timing of menopausal hormone therapy and breast cancer risk: individual participant meta-analysis of the worldwide epidemiological evidence.
    Lancet. 2019 Aug 29. pii: S0140-6736(19)31709.
    PubMed     Text format     Abstract available


    Lancet Oncol

  51. MIRZA MR, Avall Lundqvist E, Birrer MJ, dePont Christensen R, et al
    Niraparib plus bevacizumab versus niraparib alone for platinum-sensitive recurrent ovarian cancer (NSGO-AVANOVA2/ENGOT-ov24): a randomised, phase 2, superiority trial.
    Lancet Oncol. 2019 Aug 29. pii: S1470-2045(19)30515.
    PubMed     Text format     Abstract available


    Oncogene

  52. ZHAO L, Wang W, Xu L, Yi T, et al
    Correction: Integrative network biology analysis identifies miR-508-3p as the determinant for the mesenchymal identity and a strong prognostic biomarker of ovarian cancer.
    Oncogene. 2019 Sep 3. pii: 10.1038/s41388-019-0896.
    PubMed     Text format     Abstract available

  53. ZHANG MH, Zhang HH, Du XH, Gao J, et al
    UCHL3 promotes ovarian cancer progression by stabilizing TRAF2 to activate the NF-kappaB pathway.
    Oncogene. 2019 Sep 2. pii: 10.1038/s41388-019-0987.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Gynecology is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: